Suppression Of Immune Response To Factor Viii In Hemophilia A Patients

Abstract

This invention relates to methods and compositions for suppressing an immune response to Factor VIII in subjects suffering from hemophilia A and having preformed inhibitor antibodies against Factor VIII, and compositions and methods that advantageously render subjects amenable to standard treatments for hemophilia A, including Factor VIII replacement therapy.


Claims
Download PDF
Document Preview
Document History
  • Publication: Apr 8, 2014
  • Application: Mar 10, 2010
    US US 72136110 A
  • Priority: Mar 10, 2010
    US US 72136110 A
  • Priority: Mar 10, 2009
    US US 15902109 P

Download Citation


Sign in to the Lens

Feedback